UK PET Chemistry 2025 – Glasgow
UK PET Chemistry is an organisation for UK students, researchers and professionals working in the field of PET chemistry. The UK PET Chemistry meetings provide a forum for the community to meet, network, present recent work and discuss issues of common interest. The UK PET Chemistry 2025 meeting will be held on the 9th September 2025, in Glasgow. It will be a one-day event and is particularly intended as a means for early career researchers (MSc, PhD, Post Docs) to gain experience in presenting at a scientific meeting. This year, we are delighted to welcome Prof Jason Lewis as our keynote speaker.
📄Please see our draft Programme; however, note that it is subject to change.
📧 For any conference related enquiries please contact: ukpetchem2025@gmail.com
🏙️ University of Glasgow
📍 3 Kelvin Way, Glasgow, G12 8NN
🗺️ You can download a map of the venue
Keynote Lecture: Prof Jason Lewis
Title: 89Zr Radiopharmaceutical Chemistry – Precision Medicine in Cancer Treatment
The use of Positron Emission Tomography (PET) for cancer imaging is a well-established and widely used molecular imaging modality both in clinical and research settings. Over the last 30 years, our ability to non-invasively diagnose, localize, and treat many forms of cancer has advanced tremendously. These diagnostic tools are now being combined with therapeutic isotopes to create “theranostics” – agents that allow for simultaneous imaging and treatment with the same drug. This talk will include both preclinical and clinical application of these cancer targeting drugs within the central premise of theranostics “see what you treat and treat what you see”.
One area of emphasis for the Lewis Lab has been centered around the remarkable specificity and selectivity of antibodies for cancer biomarkers have made immunoglobulins some of the most flexible and adaptable tools in modern medicine. For therapeutic purposes, a wide range of non-labeled antibodies has now entered the clinic. Antibody-based PET and SPECT imaging agents are not far behind. For example, an array of 89Zr-labeled radioimmunoconjugates has shown significant promise in both preclinical and clinical studies. Zirconium-89 has a number of distinct advantages which make it ideal for ImmunoPET including that the radioactive half-life of 78.4 h matches closely the extend times required for optimum biodistribution of intact mAbs. This presentation will review the current state-of-the-art on the use of radiometals with antibody constructs.
🔗 You can access the abstract portal here.
Before submitting your abstract, thank you for paying attention to the following guidelines:
-
-
-
- Your abstract (without the title, list of authors and references) must not exceed 300 words.
- In order to easily prepare the proceedings, we ask you to prepare your text in Calibri, size 11, justify alignment, single spaced.
- The abstract template is below. If you intend to submit two abstracts, please make two different submissions.
- Save the abstract template as a Word file (.doc or .docx).
- ***Name the file(s) inserting your last name and the number of your abstract, i.e., Smith1_UKPETCHEM2025_abstract.doc for your first abstract and Smith2_UKPETCHEM2025_abstract.doc if you are submitting a second abstract.
-
-
📄You can download the Abstract template.
📅 Abstract Submission is now closed.
📄Oral presentation guidelines can be found here
📄Poster and Lightning presentation guidelines can be found here
Registration for the 2025 UK PET Chemistry Meeting is now open.
🔗You can register via the following link: Eventbrite Link.
💰Registration Fees:
-
- Standard Fee: £80.00
- Discounted Fee (Students and Early Career Researchers): £30.00
- Technical Staff: Free. Following registration, please provide proof of technical status signed by your line manager and send it to ukpetchem2025@gmail.com
🧳Peter Horlock Travel Bursary
This is a funding scheme that is open to technical staff to attend the UK PET Chemistry 2025 conference in Glasgow. For detailed information and guidance for applicants please visit here.
📅 Registration deadline: 19th August (Refunds up to 21 days before the event)
Please note that refunds will be issued up to 21 days before the event; however, the Eventbrite fee is non-refundable (standard rate fee: £7.38, discounted rate fee: £3.22 )
With thanks to our generous sponsors & supporters
Comecer develops and manufactures high-tech systems in the Radiopharmaceutical field, offering customised equipment for Therapeutical, GMP Radiopharmacy and Nuclear Medicine applications, as well as isolation technology solutions in the field of Aseptic Processing and Containment for the Pharmaceutical industry. Comecer products are used in the most advanced and prestigious research centres, universities, hospitals and pharmaceutical companies worldwide.
Curium is a global leader in nuclear medicine, specializing in developing, manufacturing, and distributing advanced radiopharmaceutical products. Serving over 14 million patients annually, we provide innovative SPECT, PET, and therapeutic solutions for life-threatening diseases. With cutting-edge facilities in Europe and the U.S., Curium combines a rich heritage with a pioneering approach to deliver excellence and unparalleled service. Named after Marie and Pierre Curie, our name reflects our commitment to advancing nuclear medicine and improving patient care worldwide.
GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, dedicated to providing integrated solutions, services, and data analytics to make hospitals more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 125 years, GE HealthCare is advancing personalized, connected, and compassionate care, while simplifying the patient’s journey across the care pathway. GE HealthCare is driving advancements in PET Radiochemistry for precision medicine. Through innovation in radiotracer development, automation, and quality control, GE HealthCare empowers researchers and clinicians to improve disease detection and personalized healthcare. Committed to scientific progress and collaboration, it strengthens the future of PET chemistry and nuclear medicine worldwide.
LabLogic Systems Ltd. is a market-leading and award-winning instrument and software provider, supporting pharmaceutical companies, agrochemical research, universities, contract research organisations, positron emission tomography (PET) and nuclear medicine facilities for over 40 years. Our systems for radioisotope detection, radiochromatography and quality control are designed and manufactured to help streamline operations and meet with demanding compliance regulations.
Life Molecular Imaging (LMI) is an international pharma company dedicated to developing and offering novel cutting-edge PET radiopharmaceuticals for imaging of neurodegenerative and cardiovascular diseases. The organization strives to be a leader in the molecular imaging field. Our mission is to pioneer innovative PET products that improve early detection and characterization of chronic and life-threatening diseases, leading to better therapeutic outcomes and improved quality of life.
Light Medical Ltd is a UK-based medical distribution company specialising in radioisotopes, pharmaceuticals, and equipment. With extensive expertise in nuclear medicine and radiopharmacy, the company connects healthcare professionals with leading British and international manufacturers, offering tailored solutions to meet clinical needs.
medicalresearchfoundation.org.uk
The Medical Research Foundation is an independent charity formed by the Medical Research Council (MRC) over 100 years ago. We invest in people and ideas wherever we see valuable research opportunities. This sponsorship is possible thanks to generous support by Cathy Horlock, in memory of her husband, Peter Horlock who worked as a radiochemistry technical officer at MRC Cyclotron Unit.
At Siemens Healthineers, we pioneer breakthroughs in healthcare. For everyone. Everywhere. Sustainably. As a leader in medical technology, we want to advance a world in which breakthroughs in healthcare create new possibilities with a minimal impact on our planet. By consistently bringing innovations to the market, we enable healthcare professionals to innovate personalised care, achieve operational excellence and transform the system of care.Our portfolio, spanning in vitro and in vivo diagnostics to image-guided therapy and cancer care, is crucial for clinical decision-making and treatment pathways. With the unique combination of our strengths in patient twinning, precision therapy, as well as digital, data and artificial intelligence (AI), we are well positioned to take on the greatest challenges in healthcare. We will continue to build on these strengths to help overcome the world’s most threatening diseases, enable efficient operations, and expand access to care.
Southern Scientific is a specialist supplier of radiation detection equipment for nuclear medicine applications including Dose Calibrators, Dose Dispensers, Gamma Cameras, Gamma Probe Systems, Gamma Counters, Liquid Scintillation Counters, Contamination Monitors, and Dosimeters.
Xiel is a specialist distributor of medical technologies in UK and Ireland. We work with global leading solution providers; therefore, continuously improving efficiency and quality for our customers and ultimately to patients. Our partners research and develop highly specific products including hardware, software, medicines, etc. for what is often a small world market. The expertise of Xiel lies in our deep understanding of the structure and organisation of Nuclear Medicine departments and Radiopharmacies in the UK and Ireland, for us to advise on the best solutions possible. Xiel exclusively represent Eckert and Ziegler, Rotop, Comecer and Telix to name a few. Please visit the booth today to meet our Nuclear Medicine experts. Xiel. Exceptional Products. Extraordinary Service. Everyday.
With thanks to our generous sponsors & supporters
 |
 |
 |
 |
|
 |
 |
 |
 |
 |